Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00633815
Other study ID # HUM00007190
Secondary ID
Status Completed
Phase N/A
First received March 4, 2008
Last updated May 9, 2017
Start date January 2008
Est. completion date November 2008

Study information

Verified date May 2017
Source University of Michigan
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Fontan-palliated patients comprise an interesting group of single-ventricle patients who are dependent upon passive return of blood from the body to the lungs. Systemic venous pressures are therefore quite elevated, and one study demonstrated that venous capacitance was diminished. In addition, these patients have markedly diminished aerobic capacity (Max VO2). Although one recent study demonstrated that Fontan patients can increase their Max VO2 through diligent cardiac rehabilitation, their ultimate results were still well below average.

It has previously been described that normal, healthy subjects have decreased exercise performance in a supine vs upright position. However, due to high venous pressures and the need for systemic venous return to overcome gravity in order to perfuse the lungs, one might hypothesize that Fontan patients would have increased exercise performance in a supine vs upright position. The investigators are interested in studying this hypothesis.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date November 2008
Est. primary completion date November 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years to 30 Years
Eligibility Inclusion Criteria:

- S/p Fontan palliation > 2 years prior

- Age 8 to 30 years

Exclusion Criteria:

- Pacemaker dependence

- Severe hypoxemia (O2 saturation <80%)

- Recent atrial flutter or other arrhythmias

- Protein losing enteropathy (PLE)

- Severe atrioventricular valve regurgitation

- History of cardiac arrest

- Significant comorbidities (renal failure, asthma, etc).

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Supine positioning
Subjects underwent exercise testing on a stationary bicycle in the supine position
Upright positioning
Subjects underwent exercise testing on a stationary bicycle in the upright position

Locations

Country Name City State
United States University of Michigan Health Systems, Pediatric Cardiology Ann Arbor Michigan

Sponsors (1)

Lead Sponsor Collaborator
University of Michigan

Country where clinical trial is conducted

United States, 

References & Publications (1)

Goldstein BH, Connor CE, Gooding L, Rocchini AP. Relation of systemic venous return, pulmonary vascular resistance, and diastolic dysfunction to exercise capacity in patients with single ventricle receiving fontan palliation. Am J Cardiol. 2010 Apr 15;105 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Exercise Capacity Watts 40 minutes
Secondary Peak Oxygen Volume (Peak VO2) milliliters per kilogram of body weight per minute (ml/kg/min) 40 minutes
Secondary Peak Heart Rate beats per minute 40 minutes
Secondary Peak Pulmonary Artery Pressure millimeters of mercury (mmHg) 40 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT05206955 - Study of Tadalafil vs. Placebo for Improving Hemodynamics and End-Organ Dysfunction in Fontan Physiology Phase 3
Enrolling by invitation NCT02659462 - Cardio Pulmonary Exercise Testing in Patients Post the Fontan Palliation in Comparison With Patients With Repaired Congenital Heart Disease and Healthy Volunteers. N/A